Head-to-head · free

Revolution Medicines, Inc. vs Siemens Healthineers AG

RVMD vs SMMNY — return on capital, cash generation, margins and balance sheet side by side.

RVMD

0 / 0

measures where RVMD leads

SMMNY

0 / 0

measures where SMMNY leads

A simple count of which company scores better on each measure — not a recommendation to buy or sell.

MeasureRVMD · FY2025SMMNY
Revenue$0—
Net income(1.1B)—
Revenue growth (yearly, multi-year)-37.2%—
Free cash flow(913.7M)—
Free cash flow margin——
Net cash / (debt)——
ROIC——
Return on equity-58.1%—
Gross margin——
Operating margin——
Net debt / EBITDA0.33x—

Figures are as reported by each company; latest fiscal year shown.

Where Revolution Medicines, Inc.'s cash went (FY2025)

Capital spending
$16.0M
Buybacks
—
Dividends
—
Acquisitions
—
Net debt issued / (repaid)
—
Full RVMD profile →

Where Siemens Healthineers AG's cash went

Not reported yet.

Full SMMNY profile →

Ask which business is stronger

"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.

Compare them free

More comparisons